Literature DB >> 10729148

Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain.

J W Balliet1, K Gendron, P Bates.   

Abstract

Short hydrophobic regions referred to as fusion peptide domains (FPDs) at or near the amino terminus of the membrane-anchoring subunit of viral glycoproteins are believed to insert into the host membrane during the initial stage of enveloped viral entry. Avian sarcoma and leukosis viruses (ASLV) are unusual among retroviruses in that the region in the envelope glycoprotein (EnvA) proposed to be the FPD is internal and contains a centrally located proline residue. To begin analyzing the function of this region of EnvA, 20 substitution mutations were introduced into the putative FPD. The mutant envelope glycoproteins were evaluated for effects on virion incorporation, receptor binding, and infection. Interestingly, most of the single-substitution mutations had little effect on any of these processes. In contrast, a bulky hydrophobic substitution for the central proline reduced viral titers 15-fold without affecting virion incorporation or receptor binding, whereas substitution of glycine for the proline had only a nominal effect on EnvA function. Similar to other viral FPDs, the putative ASLV FPD has been modeled as an amphipathic helix where most of the bulky hydrophobic residues form a patch on one face of the helix. A series of alanine insertion mutations designed to interrupt the hydrophobic patch on the helix had differential effects on infectivity, and the results of that analysis together with the results observed with the substitution mutations suggest no correlation between maintenance of the hydrophobic patch and glycoprotein function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729148      PMCID: PMC111882          DOI: 10.1128/jvi.74.8.3731-3739.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Conformation of membrane fusion-active 20-residue peptides with or without lipid bilayers. Implication of alpha-helix formation for membrane fusion.

Authors:  S Takahashi
Journal:  Biochemistry       Date:  1990-07-03       Impact factor: 3.162

Review 2.  Viral and cellular membrane fusion proteins.

Authors:  J M White
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

3.  A general model for the transmembrane proteins of HIV and other retroviruses.

Authors:  W R Gallaher; J M Ball; R F Garry; M C Griffin; R C Montelaro
Journal:  AIDS Res Hum Retroviruses       Date:  1989-08       Impact factor: 2.205

4.  Oligomeric structure of a prototype retrovirus glycoprotein.

Authors:  D Einfeld; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

6.  Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the "fusion peptide".

Authors:  C Harter; P James; T Bächi; G Semenza; J Brunner
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

7.  Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin.

Authors:  D A Steinhauer; S A Wharton; J J Skehel; D C Wiley
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  The mode of insertion of the paramyxovirus F1 N-terminus into lipid matrix, an initial step in host cell/virus fusion.

Authors:  R Brasseur; P Lorge; E Goormaghtigh; J M Ruysschaert; D Espion; A Burny
Journal:  Virus Genes       Date:  1988-07       Impact factor: 2.332

9.  Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein.

Authors:  J M Gilbert; L D Hernandez; J W Balliet; P Bates; J M White
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Influenza hemagglutinin assumes a tilted conformation during membrane fusion as determined by attenuated total reflection FTIR spectroscopy.

Authors:  S A Tatulian; P Hinterdorfer; G Baber; L K Tamm
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

View more
  7 in total

1.  Structural and functional properties of an unusual internal fusion peptide in a nonenveloped virus membrane fusion protein.

Authors:  Maya Shmulevitz; Raquel F Epand; Richard M Epand; Roy Duncan
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Features of a spatially constrained cystine loop in the p10 FAST protein ectodomain define a new class of viral fusion peptides.

Authors:  Christopher Barry; Tim Key; Rami Haddad; Roy Duncan
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

3.  The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.

Authors:  Laurie J Earp; Sue E Delos; Robert C Netter; Paul Bates; Judith M White
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.

Authors:  Robert C Netter; Sean M Amberg; John W Balliet; Mark J Biscone; Arwen Vermeulen; Laurie J Earp; Judith M White; Paul Bates
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state.

Authors:  Charles J Russell; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion.

Authors:  Angeline Rose Babel; James Bruce; John A T Young
Journal:  PLoS One       Date:  2007-01-24       Impact factor: 3.240

7.  Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.

Authors:  Xian-Yang Zhang; Robert H Kutner; Agnieszka Bialkowska; Michael P Marino; William B Klimstra; Jakob Reiser
Journal:  Retrovirology       Date:  2010-01-25       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.